Cosmegen is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Dactinomycin.
| Product ID | 55292-811_137c07d7-e2bf-4f59-8b8f-4ebe119e576d |
| NDC | 55292-811 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cosmegen |
| Generic Name | Dactinomycin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1964-12-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050682 |
| Labeler Name | RECORDATI RARE DISEASES, INC. |
| Substance Name | DACTINOMYCIN |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1964-12-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050682 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1964-12-10 |
| Ingredient | Strength |
|---|---|
| DACTINOMYCIN | .5 mg/mL |
| SPL SET ID: | 9914e793-a49c-eb00-1ab7-f606c786fe25 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 55292-811 | Cosmegen | dactinomycin |
| 39822-2100 | dactinomycin | dactinomycin |
| 42658-008 | Dactinomycin | dactinomycin |
| 55150-431 | DACTINOMYCIN | DACTINOMYCIN |
| 55150-928 | DACTINOMYCIN | DACTINOMYCIN |
| 66993-489 | Dactinomycin | Dactinomycin |
| 67457-513 | Dactinomycin | Dactinomycin |
| 67457-928 | Dactinomycin | Dactinomycin |
| 71288-129 | Dactinomycin | Dactinomycin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() COSMEGEN 72164543 0759115 Live/Registered |
MERCK & CO., INC. 1963-03-13 |
![]() COSMEGEN 71669782 0604749 Dead/Expired |
MERCK & CO., INC. 1954-07-12 |